» Articles » PMID: 34303707

Metformin Inhibits MAPK Signaling and Rescues Pancreatic Aquaporin 7 Expression to Induce Insulin Secretion in Type 2 Diabetes Mellitus

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2021 Jul 25
PMID 34303707
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Metformin is the first-line antidiabetic agent for type 2 diabetes mellitus (T2DM) treatment. Although accumulated evidence has shed light on the consequences of metformin action, the precise mechanisms of its action, especially in the pancreas, are not fully understood. Aquaporin 7 (AQP7) acts as a critical regulator of intraislet glycerol content, which is necessary for insulin production and secretion. The aim of this study was to investigate the effects of different doses of metformin on AQP7 expression and explore the possible mechanism of its protective effects in the pancreatic islets. We used an in vivo model of high-fat diet in streptozocin-induced diabetic rats and an in vitro model of rat pancreatic β-cells (INS-1 cells) damaged by hyperglycemia and hyperlipidemia. Our data showed that AQP7 expression levels were decreased, whereas p38 and JNK mitogen-activated protein kinases (MAPKs) were activated in vivo and in vitro in response to hyperglycemia and hyperlipidemia. T2DM rats treated with metformin demonstrated a reduction in blood glucose levels and increased regeneration of pancreatic β-cells. In addition, metformin upregulated AQP7 expression as well as inhibited activation of p38 and JNK MAPKs both in vivo and in vitro. Overexpression of AQP7 increased glycerol influx into INS-1 cells, whereas inhibition of AQP7 reduced glycerol influx, thereby decreasing subsequent insulin secretion. Our findings demonstrate a new mechanism by which metformin suppresses the p38 and JNK pathways, thereby upregulating pancreatic AQP7 expression and promoting glycerol influx into pancreatic β-cells and subsequent insulin secretion in T2DM.

Citing Articles

Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Promotes Hyperglycemia and Susceptibility to Streptozotocin-Induced Diabetes in Female Mice In Vivo.

Ghimire N, Welch M, Secunda C, Fink A, Lawan A Cells. 2025; 14(4).

PMID: 39996734 PMC: 11853640. DOI: 10.3390/cells14040261.


Network pharmacology-based study on the mechanism of Tangfukang formula against type 2 diabetes mellitus.

Kai Y, Wei W, Yan W, Huijuan G, Xingzhong F J Tradit Chin Med. 2025; 45(1):76-88.

PMID: 39957161 PMC: 11764938. DOI: 10.19852/j.cnki.jtcm.2025.01.007.


Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose-High-Lipid Conditions: A Comparative Study.

Gojani E, Wang B, Li D, Kovalchuk O, Kovalchuk I Int J Mol Sci. 2025; 26(1.

PMID: 39796271 PMC: 11720205. DOI: 10.3390/ijms26010421.


Inhibition of Sat1 alleviates myocardial ischemia-reperfusion injury through regulation of ferroptosis via MAPK/ERK pathway.

Liu Z, Chen H, Song Y, Chen K, Pan S, Yang S Front Pharmacol. 2024; 15:1476718.

PMID: 39605920 PMC: 11599858. DOI: 10.3389/fphar.2024.1476718.


Impact of high-fructose diet and metformin on histomorphological and molecular parameters of reproductive organs and vaginal microbiota of female rat.

Demirel M, Sumlu E, Ozercan I, Sahin K, Tuzcu M, Bay V Sci Rep. 2024; 14(1):27463.

PMID: 39523383 PMC: 11551161. DOI: 10.1038/s41598-024-76211-5.


References
1.
Galant D, Gaborit B, Desgrouas C, Abdesselam I, Bernard M, Levy N . A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy. Cells. 2016; 5(2). PMC: 4931670. DOI: 10.3390/cells5020021. View

2.
Noel R, Antinozzi P, McGarry J, Newgard C . Engineering of glycerol-stimulated insulin secretion in islet beta cells. Differential metabolic fates of glucose and glycerol provide insight into mechanisms of stimulus-secretion coupling. J Biol Chem. 1997; 272(30):18621-7. DOI: 10.1074/jbc.272.30.18621. View

3.
Lawrence M, Borenstein-Auerbach N, McGlynn K, Kunnathodi F, Shahbazov R, Syed I . NFAT targets signaling molecules to gene promoters in pancreatic β-cells. Mol Endocrinol. 2014; 29(2):274-88. PMC: 4318885. DOI: 10.1210/me.2014-1066. View

4.
Li Z, Liu H, Niu Z, Zhong W, Xue M, Wang J . Temporal Proteomic Analysis of Pancreatic β-Cells in Response to Lipotoxicity and Glucolipotoxicity. Mol Cell Proteomics. 2018; 17(11):2119-2131. PMC: 6210228. DOI: 10.1074/mcp.RA118.000698. View

5.
Li W, Yan Y, Zheng Z, Zhu Q, Long Q, Sui S . Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma. Cell Death Dis. 2020; 11(11):1011. PMC: 7689448. DOI: 10.1038/s41419-020-03218-x. View